Endoscopic Reconstruction of the Anterior Skull Base Following Tumor Resection: Application of a Novel Bioabsorbable Plate
The Laryngoscope · 2023-05 · 133 (5) · 1092-1098
DOI: 10.1002/lary.30501 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 07.12.2022. Verfasst von Anthony J Piscopo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University of Iowa, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Plastic Surgery Procedures, Skull Base Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
Endoscopic repair of skull base defects is required following resection of intracranial pathology via the endoscopic endonasal approach (EEA). Many closure techniques have been described, but choosing between techniques remains controversial. We report outcomes of 560 EEA procedures of skull base reconstruction performed on 508 patients over a 15‐year‐period. Halfway through this period, we adopted the use of a rigid, bioabsorbable extrasellar plate for reconstruction, enabling a comparison between this technique and those used previously.
Methods
All patients undergoing EEA from 2005 to 2019 at our institution were retrospectively reviewed. Demographic information, surgical pathology, tumor dimensions and radiographic features, reconstructive technique, and patient‐related outcomes were collected and analyzed with univariate and multivariate statistical modeling.
Results
Five‐hundred sixty procedures were performed on 508 patients. The series complication rate was 8.2%. Overall, cerebrospinal fluid (CSF) leak rate was 5.0% but varied significantly across closure techniques ( p < 0.001). Critically, the CSF leak rate in the 272 cases prior to our 2013 adoption of the Resorb‐X Plate (RXP) was 8.5%, whereas leak rate in the subsequent 288 cases was 1.7%. RXP was protective against CSF leak ( p = 0.001), whereas gross total resection (GTR) correlated with increased leak rate ( p = 0.001). Patient BMI was significantly associated with risk of leak ( p = 0.047). Other variables did not impact leak risk.
Conclusion
Reconstructive technique, extent of resection, and patient BMI significantly contributed to CSF leak rate. GTR was associated with increased leak risk while the RXP was protective. The bioabsorbable RXP is an effective option for rigid skull base repair with comparatively few complications. Level of Evidence 3 Laryngoscope , 133:1092–1098, 2023
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, University of Iowa, Iowa City, Iowa, USA.
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Otolaryngology, University of Iowa, Iowa City, Iowa, USA.
ORCID-Profile: Mark C Dougherty, Jeremy D W Greenlee
Zitieren
APA
Piscopo, A. J., Dougherty, M. C., Woodiwiss, T. R., Ankrah, N. K., Hughes, T., Seaman, S. C., Walsh, J. E., Graham, S. M., & Greenlee, J. D. W. (2023). Endoscopic Reconstruction of the Anterior Skull Base Following Tumor Resection: Application of a Novel Bioabsorbable Plate. The Laryngoscope, 133(5), 1092-1098. https://doi.org/10.1002/lary.30501
Vancouver
Piscopo AJ, Dougherty MC, Woodiwiss TR, Ankrah NK, Hughes T, Seaman SC, et al. Endoscopic Reconstruction of the Anterior Skull Base Following Tumor Resection: Application of a Novel Bioabsorbable Plate. The Laryngoscope. 2023;133(5):1092-1098. doi:10.1002/lary.30501
BibTeX
@article{Piscopo2023,
author = {Piscopo, Anthony J and Dougherty, Mark C and Woodiwiss, Timothy R and Ankrah, Nii-Kwanchie and Hughes, Tyler and Seaman, Scott C and Walsh, Jarrett E and Graham, Scott M and Greenlee, Jeremy D W},
title = {Endoscopic Reconstruction of the Anterior Skull Base Following Tumor Resection: Application of a Novel Bioabsorbable Plate},
journal = {The Laryngoscope},
year = {2023},
volume = {133},
number = {5},
pages = {1092--1098},
doi = {10.1002/lary.30501}
}
EUVIMED